Search

You searched for "bowel"

483 results found

Conference apps

1 March 2018 | | Technological Developments
With conference season soon starting I thought I would run through some of the apps I think would be useful for delegates attending a urology conference in the coming year. The conference app It is often useful to download the...

The emerging role of physician associates in urology

1 November 2015 | | Andrology, Basic Science Research, Endourology and Stones, Functional Urology, Infection, Neurourology, Paediatric Urology, Reconstructive Urology, Technological Developments, Trauma and Emergency Urology, Urologic Oncology, Uroradiology
The physician associate (PA) is a new role in the NHS which has expanded across medical and surgical specialties to include urology. In the USA, it has long been an established field of practice where physician assistants work autonomously within...

Characteristics of APC and the usefulness of MP-MRI for diagnosis

1 November 2016 | | Urologic Oncology | prostatic neoplasms, neoplasm recurrence, local, magnetic resonance imaging, diagnostic imaging, prognosis
The authors evaluated the pathological and oncological characteristics of anteriorly located prostate cancer (APC) in 728 RP specimens, and the accuracy of multiparametric magnetic resonance imaging (MP-MRI) for APC evaluation. Patients were characterised as APC (70% or more of tumour...

Age does not impact risk for urethroplasty complications after TIP repair of hypospadias

1 March 2014 | | Paediatric Urology, Reconstructive Urology
This paper is evidence of an increasing trend (especially in the USA) to lower the age at which hypospadias repair is undertaken. The current generalised best accepted age to repair hypospadias is between 6-18 months, which was reduced in the...

Comparison of pathological stage in patients treated with and without neoadjuvant chemotherapy for high-risk UTUC

1 March 2019 | | Urologic Oncology | carcinoma, chemotherapy, kidney neoplasms, neoadjuvant therapy, transitional cell, ureteral neoplasms
High-risk upper tract urothelial carcinoma (UTUC) has been associated with poor survival outcomes. The authors evaluated the role of neoadjuvant chemotherapy in high-risk cases prior to radical nephroureterectomy (RNU) in terms of pathological stage of the final surgical specimen. A...
The Journal of Urology cover image.

Synthetic mid-urethral slings for stress incontinence in neurogenic LUTD

11 July 2023 | | Functional Urology, Reconstructive Urology | neurogenic, stress, suburethral slings, urinary bladder, urinary incontinence
Neurogenic lower urinary tract dysfunction (NLUTD) is heterogeneous because of the multiplicity of underlying causes and mechanisms. In women with NLUTD, stress urinary incontinence may be due to intrinsic sphincter deficiency caused by the neurological disease itself or from sphincter...

LUTS update

8 January 2024 | | Functional Urology
Case study A 70-year-old, generally fit and well male attends your outpatient clinic. He has experienced a gradual deterioration in his voiding over the last few months. Specifically, he reports hesitancy, poor flow and nocturia. He denies visible haematuria. His...
The Journal of Urology cover image.

Can you boost your bladder with vitamin D?

4 July 2024 | | Paediatric Urology
Bladder overactivity is a common problem affecting the social functioning of children. Overactive bladder dry (OAB-dry) is a term (one not utilised by the International Children’s Continence Society) and refers to patients who are experiencing frequency, urgency and nocturia symptoms...

ICS updates on continence care: making sense of detrusor underactivity and the underactive bladder

1 July 2016 | | Functional Urology
Countless epidemiological studies have established the frequent occurrence of lower urinary tract symptoms (LUTS) and the significant burden these symptoms incur. For the most part of the past three decades, there has been an overwhelming focus on detrusor overactivity (DO)...

Bladder cancer diagnosis and follow up: A new proven urinary biomarker to support the post COVID-19 recovery phase

7 September 2020
Since lockdown began most urologists have been following the advice of BAUS Oncology, to minimise the risk of exposure of patients and staff to potential COVID-19 infection: the result is an increasing backlog of patients requiring tests to determine if...

Erectile dysfunction part II: treatment

1 May 2014 | | Andrology
Introduction The identification of specific risk factors associated with erectile dysfunction (ED) allows patients with mild or moderate ED to undergo a series of lifestyle changes, which may provide enough improvement in the erectile function to avoid pharmacotherapies. Cessation of...

Update on immunotherapy for non-muscle invasive transitional cell carcinoma of the bladder

7 January 2021 | | Urologic Oncology
Patients with high-risk non-muscle invasive bladder cancer (NMIBC) that have failed Bacillus Calmette-Guérin (BCG) treatment are a difficult group to treat, and many may not be suitable for the preferred treatment option of radical cystectomy. Bladder-preserving treatments for BCG-unresponsive high-risk...